82 related articles for article (PubMed ID: 22760168)
1. Can mirtazapine counteract the weight loss associated with Alzheimer disease? A retrospective open-label study.
Segers K; Surquin M
Alzheimer Dis Assoc Disord; 2014; 28(3):291-3. PubMed ID: 22760168
[TBL] [Abstract][Full Text] [Related]
2. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
Fox CB; Treadway AK; Blaszczyk AT; Sleeper RB
Pharmacotherapy; 2009 Apr; 29(4):383-97. PubMed ID: 19323618
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
Quimby JM; Lunn KF
Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine for treatment of depression and comorbidities in Alzheimer disease.
Raji MA; Brady SR
Ann Pharmacother; 2001 Sep; 35(9):1024-7. PubMed ID: 11573849
[TBL] [Abstract][Full Text] [Related]
5. Potential role of mirtazapine in underweight older adults.
Hilas O; Avena-Woods C
Consult Pharm; 2014 Feb; 29(2):124-30. PubMed ID: 24513422
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of mirtazapine for appetite loss and nausea of the cancer patient--from clinical experience in Memorial Sloan-Kettering Cancer Center].
Ito T; Okubo Y; Roth A
Gan To Kagaku Ryoho; 2009 Apr; 36(4):623-6. PubMed ID: 19381036
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
8. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C
Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss.
Poole M; Quimby JM; Hu T; Labelle D; Buhles W
J Vet Pharmacol Ther; 2019 Mar; 42(2):179-188. PubMed ID: 30506924
[TBL] [Abstract][Full Text] [Related]
11. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder.
Coskun M; Karakoc S; Kircelli F; Mukaddes NM
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):203-6. PubMed ID: 19364298
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant use in underweight older adults.
Avena-Woods C; Hilas O
Consult Pharm; 2012 Dec; 27(12):868-70. PubMed ID: 23229075
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Appetite-Stimulating Medications in the Inpatient Setting.
Howard ML; Hossaini R; Tolar C; Gaviola ML
Ann Pharmacother; 2019 Mar; 53(3):261-267. PubMed ID: 30229678
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study.
Yeephu S; Suthisisang C; Suttiruksa S; Prateepavanich P; Limampai P; Russell IJ
Ann Pharmacother; 2013; 47(7-8):921-32. PubMed ID: 23737510
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats.
Quimby JM; Gustafson DL; Lunn KF
J Vet Intern Med; 2011; 25(5):985-9. PubMed ID: 21985134
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial.
Chung MY; Min KH; Jun YJ; Kim SS; Kim WC; Jun EM
Hum Psychopharmacol; 2004 Oct; 19(7):489-94. PubMed ID: 15378676
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
Gambi F; De Berardis D; Campanella D; Carano A; Sepede G; Salini G; Mezzano D; Cicconetti A; Penna L; Salerno RM; Ferro FM
J Psychopharmacol; 2005 Sep; 19(5):483-7. PubMed ID: 16166185
[TBL] [Abstract][Full Text] [Related]
20. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Kraus T; Haack M; Schuld A; Hinze-Selch D; Koethe D; Pollmächer T
Pharmacopsychiatry; 2002 Nov; 35(6):220-5. PubMed ID: 12518269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
